Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AramarkARMK · Entity 3359 | Director · Chairman, President and CEO | May 30, 2019 | June 03, 2019 |
| Cigna GroupCI · Entity 550 | Director | April 22, 2026 | April 24, 2026 |
| O-I Glass, Inc. /DE/OI · Entity 4907 | Director | May 15, 2025 | May 19, 2025 |
| Primo Brands CorpPRMB · Entity 3622 | Director · Exec. Chair and CEO | August 10, 2026 | August 12, 2026 |
| Primo Water Corp /CN/PRMW · Entity 86195 | Director | November 08, 2024 | November 12, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aramark
Report date May 30, 2019 · Filed June 03, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,680,411.584 |
Reported balance
After 2019-05-30 transaction · row 1
1 source rowRow 1 · 2019-05-30 · Grant · Acquired 468.041 · Balance 1,680,411.584 F1: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.
Cigna Group
Report date April 22, 2026 · Filed April 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.01 Par ValueSEC Table I · non-derivative | Direct | 36,696 |
Reported balance
After 2026-04-22 transaction · row 1
1 source rowRow 1 · 2026-04-22 · Grant · Acquired 782 · Balance 36,696 |
O-I Glass, Inc. /DE/
Report date May 15, 2025 · Filed May 19, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (Direct)SEC Table I · non-derivative | Direct | 22,646 |
Reported balance
After 2025-05-15 transaction · row 1
1 source rowRow 1 · 2025-05-15 · Grant · Acquired 11,713 · Balance 22,646 F1: The restricted stock units vest in full on the date of the Company's next Annual Meeting of share owners at which directors are elected following the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units vest in full on the date of the Company's next Annual Meeting of share owners at which directors are elected following the date of grant.
Primo Brands Corp
Report date August 10, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 573,806 |
Ending reported balance
After 2026-08-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-10 · Purchase · Acquired 83,900 · Balance 573,706 F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $23.30 to $24.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Row 2 · 2026-08-10 · Purchase · Acquired 100 · Balance 573,806 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $23.30 to $24.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
Primo Water Corp /CN/
Report date November 08, 2024 · Filed November 12, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-11-08 transaction · row 1
1 source rowRow 1 · 2024-11-08 · Disposition to issuer · Disposed 18,445 · Balance 0 F1: Pursuant to that certain Arrangement Agreement and Plan of Merger, dated June 16, 2024, (as amended, the "Arrangement Agreement"), by and among the Issuer, Triton Water Parent, Inc. ("BlueTriton"), Triton US HoldCo, Inc., a wholly-owned subsidiary of BlueTriton ("Primo Brands Corporation" formerly referred to as "NewCo"), Triton Merger Sub 1, Inc., a wholly-owned subsidiary of Primo Brands Corporation and 1000922661 Ontario Inc., a wholly-owned subsidiary of Primo Brands Corporation, the reported securities were disposed of in exchange for shares of Primo Brands Corporation Class A common stock at an exchange ratio of 1:1. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to that certain Arrangement Agreement and Plan of Merger, dated June 16, 2024, (as amended, the "Arrangement Agreement"), by and among the Issuer, Triton Water Parent, Inc. ("BlueTriton"), Triton US HoldCo, Inc., a wholly-owned subsidiary of BlueTriton ("Primo Brands Corporation" formerly referred to as "NewCo"), Triton Merger Sub 1, Inc., a wholly-owned subsidiary of Primo Brands Corporation and 1000922661 Ontario Inc., a wholly-owned subsidiary of Primo Brands Corporation, the reported securities were disposed of in exchange for shares of Primo Brands Corporation Class A common stock at an exchange ratio of 1:1.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Cigna Holding Co
Report date December 20, 2018 · Filed December 26, 2018
Section 16 reporting ended · disclosed 2018-12-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.25 Par ValueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-12-20 transaction · row 1
1 source rowRow 1 · 2018-12-20 · Disposition to issuer · Disposed 14,346 · Balance 0 F1: Reflects disposition in connection with the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote) F2: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects disposition in connection with the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote)
F2: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30.
Diversey Holdings, Ltd.
Report date July 05, 2023 · Filed July 06, 2023
Section 16 reporting ended · disclosed 2023-07-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, $0.0001 par valueSEC Table I · non-derivative | IndirectEric J. Foss Revocable Trust Agreement | 0 |
Reported balance
After 2023-07-05 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2023-07-05 · Disposition to issuer · Disposed 121,210 · Balance 0 F1: Pursuant to and in connection with the transactions contemplated by that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 8, 2023, by and among the Issuer, Olympus Water Holdings IV, L.P. ("Parent"), acting by its general partner, Olympus Water Holdings Limited and Diamond Merger Limited, each of the Issuer's ordinary shares, par value $0.0001 per share (each, an "Ordinary Share"), owned by the Reporting Person were cancelled and exchanged into the right to receive $8.40 in cash (the "Merger Consideration"). F2: The number of shares reported were indirectly held within the Eric J. Foss Revocable Trust Agreement u/a/d 10/4/07 of which the Reporting Person is trustee. |
| Ordinary Shares, $0.0001 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-07-05 transaction · row 2
1 source rowRow 2 · 2023-07-05 · Disposition to issuer · Disposed 634,350 · Balance 0 F1: Pursuant to and in connection with the transactions contemplated by that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 8, 2023, by and among the Issuer, Olympus Water Holdings IV, L.P. ("Parent"), acting by its general partner, Olympus Water Holdings Limited and Diamond Merger Limited, each of the Issuer's ordinary shares, par value $0.0001 per share (each, an "Ordinary Share"), owned by the Reporting Person were cancelled and exchanged into the right to receive $8.40 in cash (the "Merger Consideration"). F3: The Ordinary Shares reported as disposed by the Reporting Person include 2,601 shares underlying restricted share units which, pursuant to the Merger Agreement, were vested and cancelled into the right to receive an amount in cash equal to the Merger Consideration, with payment subject to continued service with Parent and its affiliates, as applicable. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to and in connection with the transactions contemplated by that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 8, 2023, by and among the Issuer, Olympus Water Holdings IV, L.P. ("Parent"), acting by its general partner, Olympus Water Holdings Limited and Diamond Merger Limited, each of the Issuer's ordinary shares, par value $0.0001 per share (each, an "Ordinary Share"), owned by the Reporting Person were cancelled and exchanged into the right to receive $8.40 in cash (the "Merger Consideration").
F2: The number of shares reported were indirectly held within the Eric J. Foss Revocable Trust Agreement u/a/d 10/4/07 of which the Reporting Person is trustee.
F3: The Ordinary Shares reported as disposed by the Reporting Person include 2,601 shares underlying restricted share units which, pursuant to the Merger Agreement, were vested and cancelled into the right to receive an amount in cash equal to the Merger Consideration, with payment subject to continued service with Parent and its affiliates, as applicable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 16, 2018 Filed Nov 20, 2018 23:19 UTC | Aramark ARMK · Entity 3359 | Tax withholdingCommon Stock | 4,831 | $36.74 | $177,490.94 |
DisclosureSEC source: 0001584509-18-000218 · wf-form4_154275595188041.xml · nonDerivative · entry 2 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,609,611.647 F2 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units. F2 · shares: Represents shares withheld to pay taxes applicable to vesting of restricted stock units. Read SEC document |
| November 15, 2018 Filed Nov 20, 2018 23:19 UTC | Aramark ARMK · Entity 3359 | GrantStock Option (Right to Buy) · Derivative | 430,623 | $0.00 Strike: $36.74 | $0.00 |
DisclosureSEC source: 0001584509-18-000218 · wf-form4_154275595188041.xml · derivative · entry 5 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,623 Underlying: Common Stock · 430,623 shares Expires 2028-11-15 F3 · derivative.exercise_date: These options to purchase shares of common stock vest in four equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| November 15, 2018 Filed Nov 20, 2018 23:19 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 65,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000218 · wf-form4_154275595188041.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,614,442.647 F1 · shares: Represents restricted stock units, which vest in four equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| November 06, 2018 Filed Nov 9, 2018 00:57 UTC | Aramark ARMK · Entity 3359 | Tax withholdingCommon Stock | 99,835 | $35.74 | $3,568,102.90 |
DisclosureSEC source: 0001584509-18-000202 · wf-form4_154172501988447.xml · nonDerivative · entry 2 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,549,118.647 F2 · kind: Represents shares withheld to pay taxes applicable to the delivery of the shares described above. F2 · shares: Represents shares withheld to pay taxes applicable to the delivery of the shares described above. Read SEC document |
| November 06, 2018 Filed Nov 9, 2018 00:57 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 242,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000202 · wf-form4_154172501988447.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,648,953.647 F1 · shares: Represents common stock earned and delivered on a performance restricted stock award previously granted in November 2015 based upon the satisfaction of certain fiscal 2018 financial performance criteria of such award. Read SEC document |
| August 31, 2018 Filed Sep 5, 2018 17:49 UTC | Cigna Holding Co CI · Entity 161580 | GrantCommon Stock, $.25 Par Value | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-013181 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,145 Read SEC document |
| August 30, 2018 Filed Sep 4, 2018 22:58 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 380.101 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000175 · wf-form4_153610188890270.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,406,379.647 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 17:27 UTC | Cigna Holding Co CI · Entity 161580 | GrantCommon Stock, $.25 Par Value | 265 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-010119 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,907 Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 22:13 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 399.875 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000122 · wf-form4_152815040352919.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,405,999.546 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:53 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 378.751 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000067 · wf-form4_152028679896275.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,405,599.671 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units and performance stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. F2 · balance_after: Reflects an annuity payment of 42,816 shares of common stock from a grantor retained annuity trust to the Reporting Person. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 17:24 UTC | Cigna Holding Co CI · Entity 161580 | GrantCommon Stock, $.25 Par Value | 229 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-005157 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,642 Read SEC document |
| January 22, 2018 Filed Sep 4, 2018 22:58 UTC | Aramark ARMK · Entity 3359 | GiftCommon Stock | 16,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000175 · wf-form4_153610188890270.xml · nonDerivative · entry 2 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 0 F2 · kind: Represents final transfer from grantor retained annuity trust. Read SEC document |
| December 20, 2017 Filed Dec 22, 2017 21:28 UTC | Aramark ARMK · Entity 3359 | Tax withholdingCommon Stock | 13,495.8847 | $42.90 | $578,973.45 |
DisclosureSEC source: 0001584509-17-000293 · wf-form4_151397810296773.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,362,404.92 F1 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units and the delivery of cash in lieu of fractional shares in accordance with the terms of the applicable award. F1 · shares: Represents shares withheld to pay taxes applicable to vesting of restricted stock units and the delivery of cash in lieu of fractional shares in accordance with the terms of the applicable award. Read SEC document |
| December 07, 2017 Filed Dec 11, 2017 23:07 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 431.6088 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-17-000269 · wf-form4_151303365256651.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,375,900.8047 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units and performance stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| November 30, 2017 Filed Dec 4, 2017 18:04 UTC | Cigna Holding Co CI · Entity 161580 | GrantCommon Stock, $.25 Par Value | 212 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-018123 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,413 Read SEC document |
| November 20, 2017 Filed Nov 21, 2017 21:55 UTC | Aramark ARMK · Entity 3359 | Tax withholdingCommon Stock | 7,514.7413 | $40.82 | $306,751.74 |
DisclosureSEC source: 0001584509-17-000239 · wf-form4_151130131007771.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,375,469.1959 F1 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units and the delivery of cash in lieu of fractional shares in accordance with the terms of the applicable award. F1 · shares: Represents shares withheld to pay taxes applicable to vesting of restricted stock units and the delivery of cash in lieu of fractional shares in accordance with the terms of the applicable award. Read SEC document |
| November 19, 2017 Filed Nov 21, 2017 00:09 UTC | Aramark ARMK · Entity 3359 | Tax withholdingCommon Stock | 41,678.8721 | $40.82 | $1,701,331.56 |
DisclosureSEC source: 0001584509-17-000225 · wf-form4_151122297541551.xml · nonDerivative · entry 3 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,382,983.9372 F2 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units and/or performance stock units and the delivery of cash in lieu of fractional shares in accordance with the terms of the applicable award. F2 · shares: Represents shares withheld to pay taxes applicable to vesting of restricted stock units and/or performance stock units and the delivery of cash in lieu of fractional shares in accordance with the terms of the applicable award. Read SEC document |
| November 18, 2017 Filed Nov 21, 2017 00:09 UTC | Aramark ARMK · Entity 3359 | Tax withholdingCommon Stock | 7,119.4592 | $40.82 | $290,616.32 |
DisclosureSEC source: 0001584509-17-000225 · wf-form4_151122297541551.xml · nonDerivative · entry 2 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,424,662.8093 F2 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units and/or performance stock units and the delivery of cash in lieu of fractional shares in accordance with the terms of the applicable award. F2 · shares: Represents shares withheld to pay taxes applicable to vesting of restricted stock units and/or performance stock units and the delivery of cash in lieu of fractional shares in accordance with the terms of the applicable award. Read SEC document |
| November 16, 2017 Filed Nov 21, 2017 00:09 UTC | Aramark ARMK · Entity 3359 | GrantStock Option (Right to Buy) · Derivative | 339,429 | $0.00 Strike: $40.74 | $0.00 |
DisclosureSEC source: 0001584509-17-000225 · wf-form4_151122297541551.xml · derivative · entry 5 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,429 Underlying: Common Stock · 339,429 shares Expires 2027-11-16 F3 · derivative.exercise_date: These options to purchase shares of common stock vest in four equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| November 16, 2017 Filed Nov 21, 2017 00:09 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 48,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-17-000225 · wf-form4_151122297541551.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,431,782.2685 F1 · shares: Represents restricted stock units, which vest in four equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 22:13 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 617.8121 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-17-000190 · wf-form4_150482242243626.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,383,181.2685 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units and performance stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 17:07 UTC | Cigna Holding Co CI · Entity 161580 | GrantCommon Stock, $.25 Par Value | 247 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-014577 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,201 Read SEC document |
| June 20, 2017 Filed Jun 22, 2017 20:25 UTC | Aramark ARMK · Entity 3359 | Tax withholdingCommon Stock | 30,771.0908 | $41.02 | $1,262,230.14 |
DisclosureSEC source: 0001584509-17-000143 · wf-form4_149816310054179.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,382,563.4564 F1 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units and the delivery of cash in lieu of fractional shares in accordance with the terms of the award. Read SEC document |
| June 06, 2017 Filed Jun 8, 2017 21:19 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 822.0642 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-17-000127 · wf-form4_149695672877652.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,413,334.5472 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units and performance stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| May 31, 2017 Filed Jun 2, 2017 18:31 UTC | Cigna Holding Co CI · Entity 161580 | GrantCommon Stock, $.25 Par Value | 279 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-010843 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,954 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:33 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 896.4091 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-17-000068 · wf-form4_148857679073504.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,112,512.483 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units and performance stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. F2 · balance_after: Reflects an annuity payment of 40,759 shares of common stock from a grantor retained annuity trust to the Reporting Person. Read SEC document |
| March 01, 2017 Filed Mar 9, 2017 22:02 UTC Amendment | Aramark ARMK · Entity 3359 | GrantCommon Stock | 896.4091 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-17-000081 · wf-form4a_148909690094482.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,412,512.483 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units and performance stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. F2 · balance_after: Reflects an annuity payment of 40,759 shares of common stock from a grantor retained annuity trust to the Reporting Person. F3 · balance_after: This amendment is being filed to correct the amount of securities directly beneficially owned following the reported transaction. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 17:48 UTC | Cigna Holding Co CI · Entity 161580 | GrantCommon Stock, $.25 Par Value | 302 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-005387 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,675 Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 21:08 UTC | Aramark ARMK · Entity 3359 | Tax withholdingCommon Stock | 64,109.8711 | $36.15 | $2,317,571.84 |
DisclosureSEC source: 0001584509-16-000563 · wf-form4_148244091776962.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,370,857.0739 F1 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units and performance stock units and the delivery of cash in lieu of fractional shares in accordance with the terms of the applicable award. F1 · shares: Represents shares withheld to pay taxes applicable to vesting of restricted stock units and performance stock units and the delivery of cash in lieu of fractional shares in accordance with the terms of the applicable award. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 22:17 UTC | Aramark ARMK · Entity 3359 | Tax withholdingCommon Stock | 6,912 | $36.29 | $250,836.48 |
DisclosureSEC source: 0001584509-16-000558 · wf-form4_148218582520087.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,434,966.945 F1 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock in accordance with the terms of the applicable award. Read SEC document |
| December 11, 2016 Filed Dec 13, 2016 21:55 UTC | Aramark ARMK · Entity 3359 | Tax withholdingCommon Stock | 83,555.5539 | $36.09 | $3,015,519.94 |
DisclosureSEC source: 0001584509-16-000553 · wf-form4_148166611893006.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,441,878.945 F1 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units and the delivery of cash in lieu of fractional shares in accordance with the terms of the award. Read SEC document |
| December 08, 2016 Filed Dec 12, 2016 22:24 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 1,750.5091 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-16-000539 · wf-form4_148158144652503.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,525,434.4989 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units and performance stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 17:05 UTC | Cigna Holding Co CI · Entity 161580 | GrantCommon Stock, $.25 Par Value | 333 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-042619 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,373 Read SEC document |
| November 21, 2016 Filed Nov 21, 2016 22:00 UTC | Aramark ARMK · Entity 3359 | PurchaseCommon Stock | 87,566 | $34.50 | $3,021,429.80 |
DisclosureSEC source: 0001584509-16-000496 · wf-form4_147976561203615.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,514,252.7628 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $34.25 to $34.79, inclusive. The reporting person undertakes to provide to Aramark, any security holder of Aramark, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 20, 2016 Filed Nov 22, 2016 22:44 UTC | Aramark ARMK · Entity 3359 | Tax withholdingCommon Stock | 7,434.4284 | $34.08 | $253,365.32 |
DisclosureSEC source: 0001584509-16-000507 · wf-form4_147985463344520.xml · nonDerivative · entry 3 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,523,683.9898 F3 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units and the delivery of cash in lieu of fractional shares in accordance with the terms of the award. F3 · shares: Represents shares withheld to pay taxes applicable to vesting of restricted stock units and the delivery of cash in lieu of fractional shares in accordance with the terms of the award. Read SEC document |
| November 19, 2016 Filed Nov 22, 2016 22:44 UTC | Aramark ARMK · Entity 3359 | Tax withholdingCommon Stock | 41,233.3446 | $34.08 | $1,405,232.38 |
DisclosureSEC source: 0001584509-16-000507 · wf-form4_147985463344520.xml · nonDerivative · entry 2 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,531,118.4182 F2 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units and performance stock units and the delivery of cash in lieu of fractional shares in accordance with the terms of the applicable award. F2 · shares: Represents shares withheld to pay taxes applicable to vesting of restricted stock units and performance stock units and the delivery of cash in lieu of fractional shares in accordance with the terms of the applicable award. Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 22:44 UTC | Aramark ARMK · Entity 3359 | GrantStock Option (Right to Buy) · Derivative | 468,086 | $0.00 Strike: $34.08 | $0.00 |
DisclosureSEC source: 0001584509-16-000507 · wf-form4_147985463344520.xml · derivative · entry 5 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,086 Underlying: Common Stock · 468,086 shares Expires 2026-11-18 F4 · derivative.exercise_date: These options to purchase shares of common stock vest in four equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 22:44 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 58,099 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-16-000507 · wf-form4_147985463344520.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,572,351.7628 F1 · shares: Represents restricted stock units, which vest in four equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| September 06, 2016 Filed Sep 8, 2016 21:20 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 1,633.2346 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-16-000465 · wf-form4_147336962064679.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,426,686.7628 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units and performance stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.